| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | GATA4 E2F4 CUX2 NKX6-1 TPRXL ERF PBX1 NR1D1 MGA EGR1 ZEB2 NR1D2 | 1.72e-05 | 1412 | 41 | 12 | GO:0000981 |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | GATA4 E2F4 CUX2 NKX6-1 PBX1 KDM6B NR1D1 MGA EGR1 CREBBP ZEB2 NR1D2 | 2.38e-05 | 1459 | 41 | 12 | GO:0000977 |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | 2.92e-05 | 1244 | 41 | 11 | GO:0000978 | |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | 3.56e-05 | 1271 | 41 | 11 | GO:0000987 | |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity, RNA polymerase II-specific | 4.53e-05 | 320 | 41 | 6 | GO:0001227 | |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity | 5.02e-05 | 326 | 41 | 6 | GO:0001217 | |
| GeneOntologyMolecularFunction | chromatin binding | 1.10e-04 | 739 | 41 | 8 | GO:0003682 | |
| GeneOntologyMolecularFunction | transcription coregulator binding | 1.92e-04 | 140 | 41 | 4 | GO:0001221 | |
| GeneOntologyMolecularFunction | SMAD binding | 7.31e-04 | 86 | 41 | 3 | GO:0046332 | |
| GeneOntologyMolecularFunction | peroxisome proliferator activated receptor binding | 8.43e-04 | 21 | 41 | 2 | GO:0042975 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | 9.24e-04 | 560 | 41 | 6 | GO:0001228 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | 9.77e-04 | 566 | 41 | 6 | GO:0001216 | |
| GeneOntologyMolecularFunction | poly(A) binding | 1.61e-03 | 29 | 41 | 2 | GO:0008143 | |
| GeneOntologyMolecularFunction | poly(U) RNA binding | 2.21e-03 | 34 | 41 | 2 | GO:0008266 | |
| GeneOntologyMolecularFunction | poly-purine tract binding | 2.62e-03 | 37 | 41 | 2 | GO:0070717 | |
| GeneOntologyMolecularFunction | poly-pyrimidine tract binding | 2.90e-03 | 39 | 41 | 2 | GO:0008187 | |
| GeneOntologyMolecularFunction | transcription coactivator binding | 5.50e-03 | 54 | 41 | 2 | GO:0001223 | |
| GeneOntologyMolecularFunction | protein serine kinase activity | 6.40e-03 | 363 | 41 | 4 | GO:0106310 | |
| GeneOntologyMolecularFunction | transcription corepressor binding | 6.54e-03 | 59 | 41 | 2 | GO:0001222 | |
| GeneOntologyMolecularFunction | nuclear receptor activity | 6.75e-03 | 60 | 41 | 2 | GO:0004879 | |
| GeneOntologyMolecularFunction | ligand-activated transcription factor activity | 6.97e-03 | 61 | 41 | 2 | GO:0098531 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | GATA4 MLLT6 E2F4 TNKS ASXL2 NKX6-1 TCF20 PBX1 KDM6B NR1D1 MGA EGR1 CREBBP ZEB2 NR1D2 | 2.98e-08 | 1390 | 41 | 15 | GO:0045944 |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | GATA4 MAGEA10 ASXL2 CUX2 NKX6-1 ERF ATN1 ZNF608 NR1D1 EGR1 CREBBP ZEB2 NR1D2 | 6.88e-08 | 1053 | 41 | 13 | GO:0000122 |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | GATA4 MAGEA10 ASXL2 CUX2 NKX6-1 ERF ATN1 ZNF608 NR1D1 EGR1 CREBBP ZEB2 NR1D2 | 1.78e-06 | 1399 | 41 | 13 | GO:0045892 |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | GATA4 MAGEA10 ASXL2 CUX2 NKX6-1 ERF ATN1 ZNF608 NR1D1 EGR1 CREBBP ZEB2 NR1D2 | 1.99e-06 | 1413 | 41 | 13 | GO:1902679 |
| GeneOntologyBiologicalProcess | circadian temperature homeostasis | 2.31e-05 | 4 | 41 | 2 | GO:0060086 | |
| GeneOntologyBiologicalProcess | central nervous system development | 8.96e-05 | 1197 | 41 | 10 | GO:0007417 | |
| GeneOntologyBiologicalProcess | response to glucose | 1.58e-04 | 260 | 41 | 5 | GO:0009749 | |
| GeneOntologyBiologicalProcess | response to hexose | 1.73e-04 | 265 | 41 | 5 | GO:0009746 | |
| GeneOntologyBiologicalProcess | response to monosaccharide | 1.95e-04 | 272 | 41 | 5 | GO:0034284 | |
| GeneOntologyBiologicalProcess | regulation of cell development | 2.43e-04 | 1095 | 41 | 9 | GO:0060284 | |
| GeneOntologyBiologicalProcess | response to carbohydrate | 3.12e-04 | 301 | 41 | 5 | GO:0009743 | |
| GeneOntologyBiologicalProcess | behavior | 3.16e-04 | 891 | 41 | 8 | GO:0007610 | |
| GeneOntologyBiologicalProcess | peptidyl-serine phosphorylation | 3.42e-04 | 307 | 41 | 5 | GO:0018105 | |
| GeneOntologyBiologicalProcess | circadian behavior | 3.79e-04 | 71 | 41 | 3 | GO:0048512 | |
| GeneOntologyBiologicalProcess | head development | 3.88e-04 | 919 | 41 | 8 | GO:0060322 | |
| GeneOntologyBiologicalProcess | peptidyl-serine modification | 4.07e-04 | 319 | 41 | 5 | GO:0018209 | |
| GeneOntologyBiologicalProcess | rhythmic behavior | 4.28e-04 | 74 | 41 | 3 | GO:0007622 | |
| GeneOntologyBiologicalProcess | neuron development | 4.59e-04 | 1463 | 41 | 10 | GO:0048666 | |
| GeneOntologyBiologicalProcess | embryonic morphogenesis | 4.62e-04 | 713 | 41 | 7 | GO:0048598 | |
| GeneOntologyBiologicalProcess | positive regulation of TOR signaling | 5.00e-04 | 78 | 41 | 3 | GO:0032008 | |
| GeneOntologyBiologicalProcess | regulation of neurogenesis | 5.04e-04 | 515 | 41 | 6 | GO:0050767 | |
| GeneOntologyBiologicalProcess | dendrite development | 5.09e-04 | 335 | 41 | 5 | GO:0016358 | |
| GeneOntologyBiologicalProcess | positive regulation of epithelial cell differentiation | 5.79e-04 | 82 | 41 | 3 | GO:0030858 | |
| GeneOntologyBiologicalProcess | cellular response to glucose stimulus | 6.08e-04 | 196 | 41 | 4 | GO:0071333 | |
| GeneOntologyBiologicalProcess | temperature homeostasis | 6.08e-04 | 196 | 41 | 4 | GO:0001659 | |
| GeneOntologyBiologicalProcess | cellular response to hexose stimulus | 6.44e-04 | 199 | 41 | 4 | GO:0071331 | |
| GeneOntologyBiologicalProcess | cellular response to monosaccharide stimulus | 6.68e-04 | 201 | 41 | 4 | GO:0071326 | |
| GeneOntologyBiologicalProcess | response to nutrient levels | 8.26e-04 | 566 | 41 | 6 | GO:0031667 | |
| GeneOntologyBiologicalProcess | cellular response to carbohydrate stimulus | 8.59e-04 | 215 | 41 | 4 | GO:0071322 | |
| GeneOntologyBiologicalProcess | multicellular organismal-level homeostasis | 8.96e-04 | 1043 | 41 | 8 | GO:0048871 | |
| GeneOntologyBiologicalProcess | intracellular glucose homeostasis | 9.05e-04 | 218 | 41 | 4 | GO:0001678 | |
| GeneOntologyBiologicalProcess | skeletal muscle cell differentiation | 9.16e-04 | 96 | 41 | 3 | GO:0035914 | |
| GeneOntologyBiologicalProcess | fibroblast activation | 1.03e-03 | 24 | 41 | 2 | GO:0072537 | |
| GeneOntologyCellularComponent | chromatin | GATA4 E2F4 CUX2 NKX6-1 ERF PBX1 NR1D1 MGA EGR1 CREBBP ZEB2 NR1D2 | 1.31e-05 | 1480 | 40 | 12 | GO:0000785 |
| GeneOntologyCellularComponent | nuclear protein-containing complex | 9.66e-04 | 1377 | 40 | 9 | GO:0140513 | |
| HumanPheno | Delayed speech and language development | DOCK7 TNIK MAST1 ASXL2 ERF AMMECR1 TCF20 ATN1 PBX1 KDM6B CREBBP ZEB2 | 2.92e-06 | 1123 | 15 | 12 | HP:0000750 |
| HumanPheno | Language impairment | DOCK7 TNIK MAST1 ASXL2 ERF AMMECR1 TCF20 ATN1 PBX1 KDM6B CREBBP ZEB2 | 5.00e-06 | 1178 | 15 | 12 | HP:0002463 |
| HumanPheno | Abnormality of the helix | 7.57e-06 | 183 | 15 | 6 | HP:0000380 | |
| HumanPheno | Abnormal helix morphology | 1.77e-05 | 212 | 15 | 6 | HP:0011039 | |
| HumanPheno | Abnormal nipple morphology | 4.96e-05 | 254 | 15 | 6 | HP:0004404 | |
| HumanPheno | Deviation of the hand or of fingers of the hand | 6.81e-05 | 564 | 15 | 8 | HP:0009484 | |
| HumanPheno | Overfolded helix | 7.44e-05 | 82 | 15 | 4 | HP:0000396 | |
| HumanPheno | Abnormal lip morphology | DOCK7 GATA4 ASXL2 ERF AMMECR1 TCF20 ATN1 PBX1 KDM6B CREBBP ZEB2 | 9.28e-05 | 1249 | 15 | 11 | HP:0000159 |
| HumanPheno | Abnormally folded helix | 1.07e-04 | 90 | 15 | 4 | HP:0008544 | |
| HumanPheno | Thin vermilion border | 1.08e-04 | 433 | 15 | 7 | HP:0000233 | |
| HumanPheno | Epicanthus | 1.26e-04 | 614 | 15 | 8 | HP:0000286 | |
| HumanPheno | Abnormal pinna morphology | DOCK7 GATA4 ASXL2 ERF AMMECR1 TCF20 ATN1 PBX1 KDM6B CREBBP ZEB2 | 1.37e-04 | 1299 | 15 | 11 | HP:0000377 |
| HumanPheno | Abnormal columella morphology | 1.44e-04 | 97 | 15 | 4 | HP:0009929 | |
| HumanPheno | Abnormality of the outer ear | DOCK7 GATA4 ASXL2 ERF AMMECR1 TCF20 ATN1 PBX1 KDM6B CREBBP ZEB2 | 1.81e-04 | 1337 | 15 | 11 | HP:0000356 |
| HumanPheno | Thin upper lip vermilion | 2.49e-04 | 339 | 15 | 6 | HP:0000219 | |
| HumanPheno | Thin lips | 2.49e-04 | 339 | 15 | 6 | HP:0000213 | |
| HumanPheno | Abnormal nasal septum morphology | 2.78e-04 | 115 | 15 | 4 | HP:0000419 | |
| HumanPheno | Abnormal hallux phalanx morphology | 2.91e-04 | 46 | 15 | 3 | HP:0010057 | |
| HumanPheno | Chiari type I malformation | 3.30e-04 | 48 | 15 | 3 | HP:0007099 | |
| HumanPheno | Abnormal external nose morphology | 3.35e-04 | 916 | 15 | 9 | HP:0010938 | |
| HumanPheno | Deviation of finger | 4.20e-04 | 537 | 15 | 7 | HP:0004097 | |
| HumanPheno | Patent ductus arteriosus | 4.78e-04 | 382 | 15 | 6 | HP:0001643 | |
| HumanPheno | Abnormality of the forehead | 4.95e-04 | 1208 | 15 | 10 | HP:0000290 | |
| HumanPheno | Disordered formal thought process | 5.05e-04 | 386 | 15 | 6 | HP:0025769 | |
| HumanPheno | Low hanging columella | 5.22e-04 | 56 | 15 | 3 | HP:0009765 | |
| HumanPheno | Abnormal upper lip morphology | 5.69e-04 | 980 | 15 | 9 | HP:0000177 | |
| HumanPheno | Bicoronal synostosis | 6.20e-04 | 13 | 15 | 2 | HP:0011318 | |
| HumanPheno | Deeply set eye | 7.28e-04 | 266 | 15 | 5 | HP:0000490 | |
| HumanPheno | Clinodactyly of the 5th finger | 7.97e-04 | 420 | 15 | 6 | HP:0004209 | |
| HumanPheno | Clinodactyly of hands | 8.07e-04 | 421 | 15 | 6 | HP:0001157 | |
| HumanPheno | Deviation of the 5th finger | 8.07e-04 | 421 | 15 | 6 | HP:0009179 | |
| HumanPheno | Abnormal nasal bridge morphology | 8.31e-04 | 1029 | 15 | 9 | HP:0000422 | |
| HumanPheno | Thick vermilion border | 9.06e-04 | 279 | 15 | 5 | HP:0012471 | |
| HumanPheno | Motor stereotypy | 9.21e-04 | 280 | 15 | 5 | HP:0000733 | |
| HumanPheno | Abnormal breast morphology | 1.03e-03 | 441 | 15 | 6 | HP:0031093 | |
| HumanPheno | Abnormal aortic valve morphology | 1.06e-03 | 289 | 15 | 5 | HP:0001646 | |
| HumanPheno | Premature thelarche | 1.07e-03 | 17 | 15 | 2 | HP:0010314 | |
| HumanPheno | Abnormality of the breast | 1.11e-03 | 447 | 15 | 6 | HP:0000769 | |
| HumanPheno | Radial deviation of finger | 1.12e-03 | 448 | 15 | 6 | HP:0009466 | |
| HumanPheno | Finger clinodactyly | 1.18e-03 | 452 | 15 | 6 | HP:0040019 | |
| HumanPheno | Abnormal hand morphology | 1.22e-03 | 1082 | 15 | 9 | HP:0005922 | |
| HumanPheno | Radial deviation of the hand or of fingers of the hand | 1.24e-03 | 456 | 15 | 6 | HP:0009485 | |
| HumanPheno | Telecanthus | 1.31e-03 | 173 | 15 | 4 | HP:0000506 | |
| HumanPheno | Abnormality of upper lip vermillion | 1.35e-03 | 464 | 15 | 6 | HP:0011339 | |
| Domain | DUF1908 | 2.54e-05 | 4 | 39 | 2 | PF08926 | |
| Domain | MA_Ser/Thr_Kinase_dom | 2.54e-05 | 4 | 39 | 2 | IPR015022 | |
| Domain | MAST_pre-PK_dom | 2.54e-05 | 4 | 39 | 2 | IPR023142 | |
| Domain | - | 2.54e-05 | 4 | 39 | 2 | 1.20.1480.20 | |
| Domain | Hud_Sxl_RNA | 1.89e-04 | 10 | 39 | 2 | IPR002343 | |
| Domain | - | 2.28e-04 | 57 | 39 | 3 | 3.30.50.10 | |
| Domain | Znf_NHR/GATA | 2.40e-04 | 58 | 39 | 3 | IPR013088 | |
| Domain | VitD_rcpt | 3.81e-04 | 14 | 39 | 2 | IPR000324 | |
| Domain | EPHD | 9.56e-04 | 22 | 39 | 2 | PS51805 | |
| Domain | ZF_PHD_2 | 1.02e-03 | 95 | 39 | 3 | PS50016 | |
| Domain | ZF_PHD_1 | 1.05e-03 | 96 | 39 | 3 | PS01359 | |
| Domain | HOMEOBOX_1 | 1.44e-03 | 236 | 39 | 4 | PS00027 | |
| Domain | HOX | 1.47e-03 | 237 | 39 | 4 | SM00389 | |
| Domain | Homeobox_dom | 1.51e-03 | 239 | 39 | 4 | IPR001356 | |
| Domain | HOMEOBOX_2 | 1.51e-03 | 239 | 39 | 4 | PS50071 | |
| Domain | - | 2.80e-03 | 283 | 39 | 4 | 1.10.10.60 | |
| Domain | KH_1 | 2.85e-03 | 38 | 39 | 2 | PF00013 | |
| Domain | KH | 3.15e-03 | 40 | 39 | 2 | SM00322 | |
| Domain | KH_dom | 3.15e-03 | 40 | 39 | 2 | IPR004087 | |
| Domain | PDZ | 3.16e-03 | 141 | 39 | 3 | PF00595 | |
| Domain | KH_TYPE_1 | 3.47e-03 | 42 | 39 | 2 | PS50084 | |
| Domain | PDZ | 3.62e-03 | 148 | 39 | 3 | SM00228 | |
| Domain | - | 3.75e-03 | 150 | 39 | 3 | 2.30.42.10 | |
| Domain | KH_dom_type_1 | 3.80e-03 | 44 | 39 | 2 | IPR004088 | |
| Domain | PDZ | 3.83e-03 | 151 | 39 | 3 | PS50106 | |
| Domain | PDZ | 3.90e-03 | 152 | 39 | 3 | IPR001478 | |
| Domain | zf-C4 | 4.15e-03 | 46 | 39 | 2 | PF00105 | |
| Domain | NUCLEAR_REC_DBD_1 | 4.15e-03 | 46 | 39 | 2 | PS00031 | |
| Domain | Znf_hrmn_rcpt | 4.15e-03 | 46 | 39 | 2 | IPR001628 | |
| Domain | Nuclear_hrmn_rcpt | 4.15e-03 | 46 | 39 | 2 | IPR001723 | |
| Domain | ZnF_C4 | 4.15e-03 | 46 | 39 | 2 | SM00399 | |
| Domain | NUCLEAR_REC_DBD_2 | 4.15e-03 | 46 | 39 | 2 | PS51030 | |
| Domain | - | 4.33e-03 | 47 | 39 | 2 | 1.10.565.10 | |
| Domain | HOLI | 4.51e-03 | 48 | 39 | 2 | SM00430 | |
| Domain | Nucl_hrmn_rcpt_lig-bd | 4.51e-03 | 48 | 39 | 2 | IPR000536 | |
| Domain | Hormone_recep | 4.51e-03 | 48 | 39 | 2 | PF00104 | |
| Domain | Homeodomain-like | 4.94e-03 | 332 | 39 | 4 | IPR009057 | |
| Domain | AGC-kinase_C | 6.09e-03 | 56 | 39 | 2 | IPR000961 | |
| Domain | AGC_KINASE_CTER | 6.09e-03 | 56 | 39 | 2 | PS51285 | |
| Domain | S_TK_X | 6.09e-03 | 56 | 39 | 2 | SM00133 | |
| Pathway | REACTOME_PTEN_REGULATION | 1.78e-04 | 139 | 29 | 4 | M27646 | |
| Pathway | WP_8P231_COPY_NUMBER_VARIATION_SYNDROME | 1.81e-04 | 54 | 29 | 3 | M48073 | |
| Pathway | REACTOME_REGULATION_OF_PTEN_GENE_TRANSCRIPTION | 2.60e-04 | 61 | 29 | 3 | M27811 | |
| Pathway | WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA | 3.14e-04 | 65 | 29 | 3 | M39682 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | 2.28e-13 | 351 | 41 | 11 | 38297188 | |
| Pubmed | GATA4 MLLT6 ASXL2 ERF TCF20 ATN1 PBX1 ANKHD1 ZNF608 MGA CREBBP ZEB2 RBMS1 EMSY | 4.56e-10 | 1429 | 41 | 14 | 35140242 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | 5.59e-09 | 908 | 41 | 11 | 19274049 | |
| Pubmed | 2.24e-08 | 407 | 41 | 8 | 12693553 | ||
| Pubmed | 2.53e-08 | 808 | 41 | 10 | 20412781 | ||
| Pubmed | 2.55e-07 | 225 | 41 | 6 | 12168954 | ||
| Pubmed | 2.81e-07 | 118 | 41 | 5 | 16971476 | ||
| Pubmed | Identification of E-box factor TFE3 as a functional partner for the E2F3 transcription factor. | 3.32e-07 | 12 | 41 | 3 | 12748276 | |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | 3.92e-07 | 398 | 41 | 7 | 35016035 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | 5.55e-07 | 857 | 41 | 9 | 25609649 | |
| Pubmed | 7.10e-07 | 268 | 41 | 6 | 33640491 | ||
| Pubmed | Circadian clock protein Rev-erbα regulates neuroinflammation. | 1.36e-06 | 2 | 41 | 2 | 30792350 | |
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 32798635 | ||
| Pubmed | Reverse Erythroblastosis Virus α Antagonism Promotes Homocysteine Catabolism and Ammonia Clearance. | 1.36e-06 | 2 | 41 | 2 | 31016736 | |
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 38142970 | ||
| Pubmed | Identification of heme as the ligand for the orphan nuclear receptors REV-ERBalpha and REV-ERBbeta. | 1.36e-06 | 2 | 41 | 2 | 18037887 | |
| Pubmed | SR9009 has REV-ERB-independent effects on cell proliferation and metabolism. | 1.36e-06 | 2 | 41 | 2 | 31127047 | |
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 32439175 | ||
| Pubmed | EGR1 and the ERK-ERF axis drive mammary cell migration in response to EGF. | 1.36e-06 | 2 | 41 | 2 | 22198386 | |
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 29723273 | ||
| Pubmed | Rev-erbα and Rev-erbβ coordinately protect the circadian clock and normal metabolic function. | 1.36e-06 | 2 | 41 | 2 | 22474260 | |
| Pubmed | SR9009 improves heart function after pressure overload independent of cardiac REV-ERB. | 1.36e-06 | 2 | 41 | 2 | 35911512 | |
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 33021965 | ||
| Pubmed | Impact of circadian nuclear receptor REV-ERBα on midbrain dopamine production and mood regulation. | 1.36e-06 | 2 | 41 | 2 | 24813609 | |
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 15910736 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 20348464 | ||
| Pubmed | The hepatocyte clock and feeding control chronophysiology of multiple liver cell types. | 1.36e-06 | 2 | 41 | 2 | 32732282 | |
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 38255844 | ||
| Pubmed | Phosphorylation of N-terminal regions of REV-ERBs regulates their intracellular localization. | 1.36e-06 | 2 | 41 | 2 | 29508494 | |
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 31800167 | ||
| Pubmed | 1.46e-06 | 963 | 41 | 9 | 28671696 | ||
| Pubmed | 1.51e-06 | 709 | 41 | 8 | 22988430 | ||
| Pubmed | 2.60e-06 | 529 | 41 | 7 | 14621295 | ||
| Pubmed | Impact of cytosine methylation on DNA binding specificities of human transcription factors. | 3.13e-06 | 544 | 41 | 7 | 28473536 | |
| Pubmed | REV-ERBα and REV-ERBβ function as key factors regulating Mammalian Circadian Output. | 4.06e-06 | 3 | 41 | 2 | 31308426 | |
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 8948627 | ||
| Pubmed | Hepatocyte SREBP signaling mediates clock communication within the liver. | 4.06e-06 | 3 | 41 | 2 | 37066875 | |
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 34705514 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 9482666 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 18454201 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 29401617 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 17892483 | ||
| Pubmed | 4.69e-06 | 209 | 41 | 5 | 36779422 | ||
| Pubmed | 4.85e-06 | 1116 | 41 | 9 | 31753913 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | 6.33e-06 | 861 | 41 | 8 | 36931259 | |
| Pubmed | Ubiquitin ligase Siah2 regulates RevErbα degradation and the mammalian circadian clock. | 8.12e-06 | 4 | 41 | 2 | 26392558 | |
| Pubmed | The nuclear receptor REV-ERBα modulates Th17 cell-mediated autoimmune disease. | 8.12e-06 | 4 | 41 | 2 | 31455731 | |
| Pubmed | 8.12e-06 | 4 | 41 | 2 | 9806899 | ||
| Pubmed | Regulation of circadian behaviour and metabolism by REV-ERB-α and REV-ERB-β. | 8.12e-06 | 4 | 41 | 2 | 22460952 | |
| Pubmed | Cross-talk among ROR alpha 1 and the Rev-erb family of orphan nuclear receptors. | 8.12e-06 | 4 | 41 | 2 | 7838158 | |
| Pubmed | Myocardial Rev-erb-Mediated Diurnal Metabolic Rhythm and Obesity Paradox. | 8.12e-06 | 4 | 41 | 2 | 35034472 | |
| Pubmed | Circadian lipid synthesis in brown fat maintains murine body temperature during chronic cold. | 8.12e-06 | 4 | 41 | 2 | 31451658 | |
| Pubmed | 9.16e-06 | 418 | 41 | 6 | 34709266 | ||
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 1.08e-05 | 430 | 41 | 6 | 35044719 | |
| Pubmed | Circadian clock component REV-ERBα controls homeostatic regulation of pulmonary inflammation. | 1.35e-05 | 5 | 41 | 2 | 29533925 | |
| Pubmed | 1.35e-05 | 5 | 41 | 2 | 36209140 | ||
| Pubmed | 1.35e-05 | 5 | 41 | 2 | 12743039 | ||
| Pubmed | 1.35e-05 | 5 | 41 | 2 | 15225550 | ||
| Pubmed | Time-Restricted Feeding Prevents Obesity and Metabolic Syndrome in Mice Lacking a Circadian Clock. | 1.35e-05 | 5 | 41 | 2 | 30174302 | |
| Pubmed | 1.35e-05 | 5 | 41 | 2 | 27462873 | ||
| Pubmed | GENE REGULATION. Discrete functions of nuclear receptor Rev-erbα couple metabolism to the clock. | 1.35e-05 | 5 | 41 | 2 | 26044300 | |
| Pubmed | 1.35e-05 | 5 | 41 | 2 | 15507449 | ||
| Pubmed | 1.44e-05 | 453 | 41 | 6 | 29656893 | ||
| Pubmed | 1.50e-05 | 1285 | 41 | 9 | 35914814 | ||
| Pubmed | 2.03e-05 | 6 | 41 | 2 | 15161102 | ||
| Pubmed | 2.03e-05 | 6 | 41 | 2 | 31586012 | ||
| Pubmed | 2.03e-05 | 6 | 41 | 2 | 18086663 | ||
| Pubmed | TH17 cell differentiation is regulated by the circadian clock. | 2.03e-05 | 6 | 41 | 2 | 24202171 | |
| Pubmed | 2.84e-05 | 7 | 41 | 2 | 16858508 | ||
| Pubmed | 3.78e-05 | 8 | 41 | 2 | 20541704 | ||
| Pubmed | 4.21e-05 | 814 | 41 | 7 | 23251661 | ||
| Pubmed | 4.23e-05 | 549 | 41 | 6 | 38280479 | ||
| Pubmed | Mga is essential for the survival of pluripotent cells during peri-implantation development. | 4.86e-05 | 9 | 41 | 2 | 25516968 | |
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | 6.74e-05 | 877 | 41 | 7 | 20211142 | |
| Pubmed | The inĀ vivo Interaction Landscape of Histones H3.1 and H3.3. | 7.44e-05 | 608 | 41 | 6 | 36089195 | |
| Pubmed | Histone acetyltransferase-dependent chromatin remodeling and the vascular clock. | 8.88e-05 | 12 | 41 | 2 | 14645221 | |
| Pubmed | 1.00e-04 | 205 | 41 | 4 | 20436479 | ||
| Pubmed | 1.05e-04 | 13 | 41 | 2 | 19524524 | ||
| Pubmed | 1.05e-04 | 13 | 41 | 2 | 20692247 | ||
| Pubmed | 1.22e-04 | 14 | 41 | 2 | 9179496 | ||
| Pubmed | 1.22e-04 | 14 | 41 | 2 | 15588942 | ||
| Pubmed | 1.31e-04 | 83 | 41 | 3 | 28794006 | ||
| Pubmed | 1.36e-04 | 222 | 41 | 4 | 37071664 | ||
| Pubmed | Gata6 is an important regulator of mouse pancreas development. | 1.61e-04 | 16 | 41 | 2 | 16887115 | |
| Pubmed | Cohesin regulates tissue-specific expression by stabilizing highly occupied cis-regulatory modules. | 1.61e-04 | 16 | 41 | 2 | 22780989 | |
| Pubmed | 1.61e-04 | 16 | 41 | 2 | 23006330 | ||
| Pubmed | 1.61e-04 | 16 | 41 | 2 | 22036096 | ||
| Pubmed | 1.72e-04 | 91 | 41 | 3 | 21194568 | ||
| Pubmed | Fezl is required for the birth and specification of corticospinal motor neurons. | 1.82e-04 | 17 | 41 | 2 | 16157277 | |
| Pubmed | 1.82e-04 | 17 | 41 | 2 | 22949513 | ||
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | 1.91e-04 | 1038 | 41 | 7 | 26673895 | |
| Pubmed | Competitive binding of E3 ligases TRIM26 and WWP2 controls SOX2 in glioblastoma. | 2.04e-04 | 732 | 41 | 6 | 34732716 | |
| Pubmed | The HOX homeodomain proteins block CBP histone acetyltransferase activity. | 2.05e-04 | 18 | 41 | 2 | 11585930 | |
| Pubmed | 2.05e-04 | 18 | 41 | 2 | 23669352 | ||
| Pubmed | 2.05e-04 | 18 | 41 | 2 | 9858769 | ||
| Pubmed | Gene expression in cortical interneuron precursors is prescient of their mature function. | 2.29e-04 | 19 | 41 | 2 | 18250082 | |
| Pubmed | Proximity interactions among centrosome components identify regulators of centriole duplication. | 2.34e-04 | 101 | 41 | 3 | 24613305 | |
| Pubmed | 2.54e-04 | 20 | 41 | 2 | 20564319 | ||
| Pubmed | 2.55e-04 | 104 | 41 | 3 | 9205841 | ||
| Pubmed | 2.58e-04 | 486 | 41 | 5 | 20936779 | ||
| Interaction | CRX interactions | GATA4 MLLT6 ASXL2 ERF TCF20 ATN1 PBX1 ZNF608 MGA CREBBP ZEB2 | 2.32e-12 | 254 | 41 | 11 | int:CRX |
| Interaction | FEV interactions | 6.63e-09 | 203 | 41 | 8 | int:FEV | |
| Interaction | TLX1 interactions | 5.79e-08 | 175 | 41 | 7 | int:TLX1 | |
| Interaction | NUP43 interactions | 3.60e-07 | 625 | 41 | 10 | int:NUP43 | |
| Interaction | SMAD1 interactions | 5.39e-07 | 243 | 41 | 7 | int:SMAD1 | |
| Interaction | TLE3 interactions | 7.60e-07 | 376 | 41 | 8 | int:TLE3 | |
| Interaction | EGR2 interactions | 1.20e-06 | 171 | 41 | 6 | int:EGR2 | |
| Interaction | HDAC1 interactions | DOCK7 GATA4 E2F4 TCF20 PBX1 ANKHD1 ZNF608 MGA CREBBP ZEB2 EMSY NR1D2 | 1.29e-06 | 1108 | 41 | 12 | int:HDAC1 |
| Interaction | HNF1B interactions | 2.22e-06 | 190 | 41 | 6 | int:HNF1B | |
| Interaction | SP7 interactions | 2.40e-06 | 304 | 41 | 7 | int:SP7 | |
| Interaction | HDAC3 interactions | 2.91e-06 | 313 | 41 | 7 | int:HDAC3 | |
| Interaction | TBXT interactions | 3.68e-06 | 116 | 41 | 5 | int:TBXT | |
| Interaction | ERG interactions | 5.58e-06 | 223 | 41 | 6 | int:ERG | |
| Interaction | MYB interactions | 7.19e-06 | 133 | 41 | 5 | int:MYB | |
| Interaction | PAX6 interactions | 8.13e-06 | 366 | 41 | 7 | int:PAX6 | |
| Interaction | YWHAH interactions | DOCK7 NAV2 MAST1 NHSL1 MAST4 TCF20 CLEC16A CREBBP RPTOR SIPA1L1 MEX3C | 8.61e-06 | 1102 | 41 | 11 | int:YWHAH |
| Interaction | FOXQ1 interactions | 9.55e-06 | 141 | 41 | 5 | int:FOXQ1 | |
| Interaction | CSNK2A2 interactions | 1.11e-05 | 718 | 41 | 9 | int:CSNK2A2 | |
| Interaction | CSNK2A1 interactions | 1.61e-05 | 956 | 41 | 10 | int:CSNK2A1 | |
| Interaction | HNF4A interactions | 1.84e-05 | 275 | 41 | 6 | int:HNF4A | |
| Interaction | HOXB7 interactions | 1.97e-05 | 26 | 41 | 3 | int:HOXB7 | |
| Interaction | SOX7 interactions | 2.30e-05 | 82 | 41 | 4 | int:SOX7 | |
| Interaction | TEAD1 interactions | 2.79e-05 | 176 | 41 | 5 | int:TEAD1 | |
| Interaction | GSC interactions | 2.90e-05 | 87 | 41 | 4 | int:GSC | |
| Interaction | HOXD4 interactions | 3.05e-05 | 30 | 41 | 3 | int:HOXD4 | |
| Interaction | KMT2A interactions | 3.87e-05 | 314 | 41 | 6 | int:KMT2A | |
| Interaction | SMG7 interactions | 4.23e-05 | 319 | 41 | 6 | int:SMG7 | |
| Interaction | MYOD1 interactions | 4.44e-05 | 194 | 41 | 5 | int:MYOD1 | |
| Interaction | HOXB2 interactions | 5.33e-05 | 36 | 41 | 3 | int:HOXB2 | |
| Interaction | RBBP7 interactions | 6.55e-05 | 507 | 41 | 7 | int:RBBP7 | |
| Interaction | EN1 interactions | 7.28e-05 | 110 | 41 | 4 | int:EN1 | |
| Interaction | XRCC6 interactions | 8.29e-05 | 928 | 41 | 9 | int:XRCC6 | |
| Interaction | HOXC4 interactions | 8.49e-05 | 42 | 41 | 3 | int:HOXC4 | |
| Interaction | NCOR1 interactions | 8.65e-05 | 363 | 41 | 6 | int:NCOR1 | |
| Interaction | TP53BP1 interactions | 8.96e-05 | 533 | 41 | 7 | int:TP53BP1 | |
| Interaction | TSC1 interactions | 9.05e-05 | 366 | 41 | 6 | int:TSC1 | |
| Interaction | KDM1A interactions | 9.22e-05 | 941 | 41 | 9 | int:KDM1A | |
| Interaction | TNIK interactions | 1.13e-04 | 381 | 41 | 6 | int:TNIK | |
| Interaction | H3-3A interactions | 1.13e-04 | 749 | 41 | 8 | int:H3-3A | |
| Interaction | SMAD2 interactions | 1.19e-04 | 385 | 41 | 6 | int:SMAD2 | |
| Interaction | PAX9 interactions | 1.39e-04 | 130 | 41 | 4 | int:PAX9 | |
| Interaction | RBBP4 interactions | 1.41e-04 | 573 | 41 | 7 | int:RBBP4 | |
| Interaction | ASF1A interactions | 1.44e-04 | 249 | 41 | 5 | int:ASF1A | |
| Interaction | TFDP1 interactions | 1.52e-04 | 133 | 41 | 4 | int:TFDP1 | |
| Interaction | PHF20 interactions | 1.71e-04 | 53 | 41 | 3 | int:PHF20 | |
| Interaction | MDC1 interactions | 1.77e-04 | 414 | 41 | 6 | int:MDC1 | |
| Interaction | NCOR2 interactions | 1.89e-04 | 264 | 41 | 5 | int:NCOR2 | |
| Interaction | PRRC2B interactions | 1.93e-04 | 265 | 41 | 5 | int:PRRC2B | |
| Interaction | MED23 interactions | 1.96e-04 | 266 | 41 | 5 | int:MED23 | |
| Interaction | KIF7 interactions | 2.17e-04 | 146 | 41 | 4 | int:KIF7 | |
| Interaction | TCF12 interactions | 2.29e-04 | 148 | 41 | 4 | int:TCF12 | |
| Interaction | BAG2 interactions | 2.33e-04 | 622 | 41 | 7 | int:BAG2 | |
| Interaction | HOXB6 interactions | 2.47e-04 | 60 | 41 | 3 | int:HOXB6 | |
| Interaction | NR5A1 interactions | 2.47e-04 | 60 | 41 | 3 | int:NR5A1 | |
| Interaction | RBFOX2 interactions | 2.65e-04 | 284 | 41 | 5 | int:RBFOX2 | |
| Interaction | SMAD3 interactions | 2.68e-04 | 447 | 41 | 6 | int:SMAD3 | |
| Interaction | RBBP5 interactions | 2.79e-04 | 287 | 41 | 5 | int:RBBP5 | |
| Interaction | KLF15 interactions | 2.92e-04 | 290 | 41 | 5 | int:KLF15 | |
| Interaction | WDR5 interactions | 3.01e-04 | 1101 | 41 | 9 | int:WDR5 | |
| Interaction | HCFC1 interactions | 3.06e-04 | 293 | 41 | 5 | int:HCFC1 | |
| Interaction | HLF interactions | 3.11e-04 | 13 | 41 | 2 | int:HLF | |
| Interaction | HUWE1 interactions | 3.20e-04 | 1110 | 41 | 9 | int:HUWE1 | |
| Interaction | SMARCA4 interactions | 3.20e-04 | 462 | 41 | 6 | int:SMARCA4 | |
| Interaction | PPP1R12B interactions | 3.57e-04 | 68 | 41 | 3 | int:PPP1R12B | |
| Interaction | NFATC1 interactions | 3.71e-04 | 168 | 41 | 4 | int:NFATC1 | |
| Interaction | YEATS2 interactions | 3.79e-04 | 169 | 41 | 4 | int:YEATS2 | |
| Interaction | SIPA1L1 interactions | 4.24e-04 | 174 | 41 | 4 | int:SIPA1L1 | |
| Interaction | SOX2 interactions | DOCK7 GATA4 NAV2 TCF20 ANKHD1 ZNF608 ZEB2 RBMS1 SIPA1L1 MEX3C | 4.40e-04 | 1422 | 41 | 10 | int:SOX2 |
| Interaction | ZSWIM8 interactions | 4.58e-04 | 74 | 41 | 3 | int:ZSWIM8 | |
| Interaction | KAT2A interactions | 4.82e-04 | 180 | 41 | 4 | int:KAT2A | |
| Interaction | ALG13 interactions | 5.12e-04 | 183 | 41 | 4 | int:ALG13 | |
| Interaction | LHX3 interactions | 5.34e-04 | 185 | 41 | 4 | int:LHX3 | |
| Interaction | E2F3 interactions | 5.55e-04 | 79 | 41 | 3 | int:E2F3 | |
| Interaction | CCAR2 interactions | 5.80e-04 | 337 | 41 | 5 | int:CCAR2 | |
| Interaction | AKAP8 interactions | 6.26e-04 | 193 | 41 | 4 | int:AKAP8 | |
| Interaction | PBX1 interactions | 6.88e-04 | 85 | 41 | 3 | int:PBX1 | |
| Interaction | FMR1 interactions | 7.01e-04 | 536 | 41 | 6 | int:FMR1 | |
| Interaction | GATA2 interactions | 7.02e-04 | 199 | 41 | 4 | int:GATA2 | |
| Interaction | KANSL3 interactions | 7.11e-04 | 86 | 41 | 3 | int:KANSL3 | |
| Interaction | E2F1 interactions | 7.15e-04 | 200 | 41 | 4 | int:E2F1 | |
| Interaction | MYCBP2 interactions | 7.34e-04 | 355 | 41 | 5 | int:MYCBP2 | |
| Interaction | SPIB interactions | 7.50e-04 | 20 | 41 | 2 | int:SPIB | |
| Interaction | MAPK1 interactions | 7.51e-04 | 543 | 41 | 6 | int:MAPK1 | |
| Interaction | PYCR1 interactions | 7.56e-04 | 203 | 41 | 4 | int:PYCR1 | |
| Interaction | FBXO45 interactions | 7.61e-04 | 88 | 41 | 3 | int:FBXO45 | |
| Interaction | YWHAE interactions | 7.86e-04 | 1256 | 41 | 9 | int:YWHAE | |
| Interaction | TERF2IP interactions | 8.18e-04 | 552 | 41 | 6 | int:TERF2IP | |
| Interaction | SON interactions | 8.28e-04 | 208 | 41 | 4 | int:SON | |
| Interaction | DYRK1B interactions | 8.39e-04 | 91 | 41 | 3 | int:DYRK1B | |
| Interaction | CTNNB1 interactions | 8.39e-04 | 1009 | 41 | 8 | int:CTNNB1 | |
| Interaction | NFIC interactions | 8.58e-04 | 210 | 41 | 4 | int:NFIC | |
| Interaction | DCAF7 interactions | 8.63e-04 | 368 | 41 | 5 | int:DCAF7 | |
| Interaction | FOXI1 interactions | 8.66e-04 | 92 | 41 | 3 | int:FOXI1 | |
| Interaction | KLF9 interactions | 8.93e-04 | 93 | 41 | 3 | int:KLF9 | |
| Interaction | HOXA5 interactions | 9.21e-04 | 94 | 41 | 3 | int:HOXA5 | |
| Interaction | KLF6 interactions | 9.50e-04 | 95 | 41 | 3 | int:KLF6 | |
| Interaction | SLX4 interactions | 9.84e-04 | 572 | 41 | 6 | int:SLX4 | |
| Interaction | HOXD10 interactions | 9.94e-04 | 23 | 41 | 2 | int:HOXD10 | |
| Interaction | RUVBL1 interactions | 1.01e-03 | 575 | 41 | 6 | int:RUVBL1 | |
| Interaction | PIN1 interactions | 1.03e-03 | 383 | 41 | 5 | int:PIN1 | |
| GeneFamily | PDZ domain containing | 2.00e-03 | 152 | 30 | 3 | 1220 | |
| GeneFamily | Nuclear hormone receptors | 2.98e-03 | 49 | 30 | 2 | 71 | |
| Coexpression | LAKE_ADULT_KIDNEY_C28_INTERSTITIUM | 9.97e-06 | 86 | 41 | 4 | M39247 | |
| Coexpression | GSE15750_DAY6_VS_DAY10_TRAF6KO_EFF_CD8_TCELL_DN | 1.44e-05 | 199 | 41 | 5 | M3583 | |
| Coexpression | JEPSEN_SMRT_TARGETS | 1.88e-05 | 33 | 41 | 3 | MM745 | |
| Coexpression | JEPSEN_SMRT_TARGETS | 1.88e-05 | 33 | 41 | 3 | M1773 | |
| Coexpression | VARELA_ZMPSTE24_TARGETS_UP | 4.50e-05 | 44 | 41 | 3 | M2085 | |
| Coexpression | VARELA_ZMPSTE24_TARGETS_UP | 4.82e-05 | 45 | 41 | 3 | MM1200 | |
| Coexpression | ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_UP | 8.66e-05 | 290 | 41 | 5 | M11616 | |
| Coexpression | BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_ACE2_EXPRESSING_CELLS_RUXOLITINIB_UP | 1.02e-04 | 486 | 41 | 6 | M34018 | |
| Coexpression | TRAVAGLINI_LUNG_BASOPHIL_MAST_2_CELL | 1.23e-04 | 503 | 41 | 6 | M41690 | |
| Coexpression | YEMELYANOV_GR_TARGETS_DN | 1.30e-04 | 11 | 41 | 2 | M17211 | |
| Coexpression | GSE3920_IFNA_VS_IFNG_TREATED_ENDOTHELIAL_CELL_UP | 1.43e-04 | 170 | 41 | 4 | M6697 | |
| Coexpression | LAKE_ADULT_KIDNEY_C4_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S2 | 1.64e-04 | 176 | 41 | 4 | M39223 | |
| Coexpression | LAKE_ADULT_KIDNEY_C26_MESANGIAL_CELLS | 1.67e-04 | 177 | 41 | 4 | M39245 | |
| Coexpression | BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_CALU3_CELLS_UP | 1.80e-04 | 339 | 41 | 5 | M34012 | |
| Coexpression | FRIDMAN_SENESCENCE_DN | 1.84e-04 | 13 | 41 | 2 | M9487 | |
| Coexpression | BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_ACE2_EXPRESSING_CELLS_UP | 1.90e-04 | 545 | 41 | 6 | M34016 | |
| Coexpression | BUSSLINGER_GASTRIC_X_CELLS | 2.24e-04 | 191 | 41 | 4 | M40019 | |
| Coexpression | GSE21033_CTRL_VS_POLYIC_STIM_DC_1H_DN | 2.57e-04 | 198 | 41 | 4 | M7716 | |
| Coexpression | GSE20152_SPHK1_KO_VS_WT_HTNFA_OVERXPRESS_ANKLE_UP | 2.57e-04 | 198 | 41 | 4 | M7684 | |
| Coexpression | GSE9006_HEALTHY_VS_TYPE_2_DIABETES_PBMC_AT_DX_DN | 2.57e-04 | 198 | 41 | 4 | M5782 | |
| Coexpression | GSE11057_CD4_CENT_MEM_VS_PBMC_UP | 2.57e-04 | 198 | 41 | 4 | M3116 | |
| Coexpression | BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP | 2.58e-04 | 822 | 41 | 7 | M6782 | |
| Coexpression | GSE14908_RESTING_VS_HDM_STIM_CD4_TCELL_ATOPIC_PATIENT_DN | 2.67e-04 | 200 | 41 | 4 | M7075 | |
| Coexpression | GSE26030_UNSTIM_VS_RESTIM_TH1_DAY15_POST_POLARIZATION_DN | 2.67e-04 | 200 | 41 | 4 | M8576 | |
| Coexpression | STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP | 2.99e-04 | 206 | 41 | 4 | M2817 | |
| Coexpression | STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP | 3.10e-04 | 208 | 41 | 4 | MM581 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | 3.30e-04 | 856 | 41 | 7 | M4500 | |
| Coexpression | TABULA_MURIS_SENIS_PANCREAS_PANCREATIC_BETA_CELL_AGEING | 3.33e-04 | 212 | 41 | 4 | MM3816 | |
| Coexpression | CAIRO_HEPATOBLASTOMA_CLASSES_DN | 3.39e-04 | 213 | 41 | 4 | M12176 | |
| Coexpression | KANG_DOXORUBICIN_RESISTANCE_DN | 4.01e-04 | 19 | 41 | 2 | M3323 | |
| Coexpression | PHONG_TNF_RESPONSE_VIA_P38_COMPLETE | 4.10e-04 | 224 | 41 | 4 | M2500 | |
| Coexpression | ZHENG_CORD_BLOOD_C4_PUTATIVE_EARLY_ERYTHROID_COMMITMENT | 4.73e-04 | 97 | 41 | 3 | M39213 | |
| Coexpression | BROWNE_HCMV_INFECTION_12HR_DN | 5.17e-04 | 100 | 41 | 3 | M5775 | |
| Coexpression | PUJANA_BREAST_CANCER_LIT_INT_NETWORK | 5.32e-04 | 101 | 41 | 3 | M15356 | |
| Coexpression | BROWNE_HCMV_INFECTION_20HR_DN | 5.48e-04 | 102 | 41 | 3 | M5601 | |
| Coexpression | DOANE_RESPONSE_TO_ANDROGEN_DN | 5.49e-04 | 242 | 41 | 4 | M12816 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_500 | 9.60e-06 | 406 | 40 | 7 | gudmap_developingGonad_e16.5_epididymis_500 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#2_top-relative-expression-ranked_500 | 1.29e-05 | 162 | 40 | 5 | gudmap_developingGonad_e16.5_epididymis_500_k2 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k-means-cluster#1_top-relative-expression-ranked_1000 | 5.79e-05 | 112 | 40 | 4 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k1_1000 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_500 | 1.00e-04 | 403 | 40 | 6 | gudmap_developingGonad_e12.5_epididymis_500 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.00e-04 | 249 | 40 | 5 | gudmap_developingGonad_P2_epididymis_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000 | 1.02e-04 | 799 | 40 | 8 | gudmap_developingGonad_e18.5_epididymis_1000 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000 | 1.04e-04 | 801 | 40 | 8 | gudmap_developingGonad_e14.5_ epididymis_1000 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000 | 1.07e-04 | 804 | 40 | 8 | gudmap_developingGonad_e12.5_ovary_1000 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_500 | 1.09e-04 | 409 | 40 | 6 | gudmap_developingGonad_e12.5_ovary_500 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000 | 1.09e-04 | 806 | 40 | 8 | gudmap_developingGonad_e12.5_epididymis_1000 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_500 | 1.14e-04 | 413 | 40 | 6 | gudmap_developingGonad_e14.5_ epididymis_500 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_top-relative-expression-ranked_500 | 1.30e-04 | 423 | 40 | 6 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_500 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.76e-04 | 281 | 40 | 5 | gudmap_developingGonad_e18.5_epididymis_1000_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder epithelial cells_emap-30875_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.14e-04 | 157 | 40 | 4 | gudmap_developingLowerUrinaryTract_e13.5_bladder epithelial cells_1000_k3 | |
| CoexpressionAtlas | alpha beta T cells, T.4+8int.Th, 4+ 8int TCRhi, Thymus, avg-3 | 2.46e-04 | 302 | 40 | 5 | GSM399362_500 | |
| CoexpressionAtlas | dev gonad_e11.5_F_SupCellPrec_Sry_k-means-cluster#4_top-relative-expression-ranked_500 | 3.24e-04 | 71 | 40 | 3 | gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_k4_500 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_k-means-cluster#3_top-relative-expression-ranked_1000 | 5.10e-04 | 354 | 40 | 5 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_k3_1000 | |
| CoexpressionAtlas | Stem Cells, SC.STSL.BM, CD117+ IL7R- CD150- CD48- AA4.1+ CD43+, Bone marrow, avg-3 | 5.50e-04 | 85 | 40 | 3 | GSM399454_100 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000 | 5.51e-04 | 776 | 40 | 7 | gudmap_developingGonad_e14.5_ ovary_1000 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_1000 | 5.60e-04 | 778 | 40 | 7 | gudmap_developingGonad_e18.5_ovary_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | 5.68e-04 | 780 | 40 | 7 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1 | |
| CoexpressionAtlas | alpha beta T cells, T.4SP69+.Th, 4+ 8- TCRhi 69+, Thymus, avg-3 | 5.86e-04 | 365 | 40 | 5 | GSM399376_500 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | 6.13e-04 | 790 | 40 | 7 | gudmap_developingGonad_e16.5_epididymis_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#1_top-relative-expression-ranked_1000 | 6.31e-04 | 209 | 40 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000_k1 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_1000 | 6.36e-04 | 795 | 40 | 7 | gudmap_developingGonad_e16.5_ovary_1000 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_1000 | 6.46e-04 | 797 | 40 | 7 | gudmap_developingGonad_P2_epididymis_1000 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_1000 | 7.37e-04 | 815 | 40 | 7 | gudmap_developingGonad_e11.5_ovary + mesonephros_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#4_top-relative-expression-ranked_1000 | 7.45e-04 | 385 | 40 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_1000 | 7.53e-04 | 818 | 40 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_top-relative-expression-ranked_1000 | 8.26e-04 | 831 | 40 | 7 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_1000 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg2+.act.Sp, TCRd+ Vg2+ CD44+, Spleen, avg-3 | 8.36e-04 | 395 | 40 | 5 | GSM476678_500 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#1_top-relative-expression-ranked_1000 | 8.57e-04 | 99 | 40 | 3 | gudmap_developingGonad_e14.5_ epididymis_1000_k1 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_500 | 9.25e-04 | 404 | 40 | 5 | gudmap_developingGonad_e18.5_epididymis_500 | |
| ToppCell | HSPCs-Ery/Mk_prog.|HSPCs / Lineage and Cell class | 7.01e-07 | 183 | 41 | 5 | 59cfb02143b6b54dfca7560562e064948f0340ca | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW26-Neuronal|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 1.06e-06 | 199 | 41 | 5 | a255484ba77bd2741a541da278efc8cf4abbe570 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.19e-05 | 179 | 41 | 4 | cb38b54261a7af5ee3347e64c8aa880a77ed0763 | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.24e-05 | 180 | 41 | 4 | b509c7d6bdfba672065fb722874bdc68de72ba1c | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Neuronal-neurons_B-Branch_B1_(eMN)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.49e-05 | 185 | 41 | 4 | ef996f4cdbc3971c6c0460d13df64b075ab22154 | |
| ToppCell | (00)_Basal-(4)_1wkpi|(00)_Basal / shred by cell type and Timepoint | 2.49e-05 | 185 | 41 | 4 | bf82ba905e5eee1c39a2731702071d3de10a78b8 | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Neuronal-neurons_B|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.49e-05 | 185 | 41 | 4 | d51342a3979bd728a80e04126059a3fd8a0dbe3b | |
| ToppCell | COVID-19-Epithelial_cells-Airway_club|COVID-19 / group, cell type (main and fine annotations) | 2.49e-05 | 185 | 41 | 4 | cfe6fd73d817e173fe803bc1683c291d9bcb8608 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.54e-05 | 186 | 41 | 4 | bd1185592aedebccd1007dbf2dd2f549fcdf9f42 | |
| ToppCell | droplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.59e-05 | 187 | 41 | 4 | 663991a8afe652e92363b64bcbd68c14d0307f0e | |
| ToppCell | HSPCs-Ery/Mk_prog.|World / Lineage and Cell class | 2.65e-05 | 188 | 41 | 4 | 5390089213cd6ee90dcdfd3c3f5b6765376cccf2 | |
| ToppCell | facs-Pancreas-Endocrine-24m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.71e-05 | 189 | 41 | 4 | 010fdd70e9d0e21b856306a29ff877776a480319 | |
| ToppCell | RA-14._Fibroblast_III|World / Chamber and Cluster_Paper | 2.71e-05 | 189 | 41 | 4 | b6e12d24d2b0735730bdc625f8318c1c9c2a9b3b | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-pulmonary_interstitial_fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.76e-05 | 190 | 41 | 4 | c7bd087f36321cec61b98657433b4d19d135791f | |
| ToppCell | droplet-Thymus-nan-18m-Lymphocytic-Double_negative_Thymocyte,_DN4_(Cd8-,_Cd4-),_some_undergoing_VDJ_recombination_|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.76e-05 | 190 | 41 | 4 | 8f5e71a0861ee4e8f3ce45e8a7f18fb9d6036a3c | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Myofibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.76e-05 | 190 | 41 | 4 | 834218fcc59df5e7e52de154272f3d55d81d0dac | |
| ToppCell | droplet-Thymus-nan-18m-Lymphocytic-double_negative_T_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.76e-05 | 190 | 41 | 4 | 84265be128170cbb08d76e824aa108e07da9c3e5 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.82e-05 | 191 | 41 | 4 | ca5669bd6f4a17471acae3eb229f845cc2e08efa | |
| ToppCell | COPD-Epithelial-Club|COPD / Disease state, Lineage and Cell class | 2.82e-05 | 191 | 41 | 4 | c909cf5fa0e6519aa93a47d2c3fcd2ae2163cd8d | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.82e-05 | 191 | 41 | 4 | a251b134f67a0a1ef3a42f50042f128a17f20b22 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.82e-05 | 191 | 41 | 4 | 7d1595e616f6f111fc2f5bc1b179c5d67d624cc9 | |
| ToppCell | 390C-Myeloid-Mast_cell|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.88e-05 | 192 | 41 | 4 | 201d430af1e4fee7bc03baf0aca17db26f6f439a | |
| ToppCell | P03-Mesenchymal-mesenchymal_fibroblast-alveolar_fibroblast_Wnt2-pa|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.88e-05 | 192 | 41 | 4 | 2802fae55683345ff94a1ecf73b6fbee4f17481e | |
| ToppCell | droplet-Lung-3m-Mesenchymal|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.88e-05 | 192 | 41 | 4 | 086b47f87283cd41139cd56686011f8b5821b0da | |
| ToppCell | Control-Epithelial-Club|Control / Disease state, Lineage and Cell class | 2.88e-05 | 192 | 41 | 4 | d84ed1ea4a03edaa18c804f75afb03bd7b1f0e16 | |
| ToppCell | 390C-Myeloid-Mast_cell-|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.88e-05 | 192 | 41 | 4 | 15c1a0a0d07106118427135f166a1da710bf621a | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.88e-05 | 192 | 41 | 4 | 0dc1f46e40346ed0b286e53b106a812441575100 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.94e-05 | 193 | 41 | 4 | 456aa8a8f1f9cbba0bd618a5f623909079c0f56b | |
| ToppCell | facs-Heart-RA-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.00e-05 | 194 | 41 | 4 | 48063c9fe3e12aeff0707acada1baa2f8621f093 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.00e-05 | 194 | 41 | 4 | ba7f971fb9a19423602da60770f23d9fead4a451 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.00e-05 | 194 | 41 | 4 | cf0244a29934e515446ac917d3c30672b460fb04 | |
| ToppCell | facs-Heart-RA-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.00e-05 | 194 | 41 | 4 | 4f31d2cf7eb37b45fefc4da5b41aac0bfdd847b3 | |
| ToppCell | Control-Multiplet|Control / Disease state, Lineage and Cell class | 3.06e-05 | 195 | 41 | 4 | 618900c80bea09d46dad3f741bd1bff8bf0a64ee | |
| ToppCell | Control-Multiplet-Multiplet|Control / Disease state, Lineage and Cell class | 3.06e-05 | 195 | 41 | 4 | 06ac685855e14e4dd2cbe6d0e73f894f2eeff91f | |
| ToppCell | P07-Mesenchymal|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.06e-05 | 195 | 41 | 4 | 859764b605866b6c3e6edd0698670ca9c0f20745 | |
| ToppCell | facs-Lung-3m|Lung / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.06e-05 | 195 | 41 | 4 | c4648c0332c3826776f9ad3f5f803dbac2b4c0c0 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Neuronal-midbrain/hindbrain_cells|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 3.12e-05 | 196 | 41 | 4 | 0767581b69bc7e6334d580ca02ed1e831b7b55da | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.12e-05 | 196 | 41 | 4 | 1450cb69c5bf469e97c03bf1890f6f7c54165b8a | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.12e-05 | 196 | 41 | 4 | 2029f58ce6a7b8c35d3a7496c3341391990909ce | |
| ToppCell | facs-Heart-RA-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.18e-05 | 197 | 41 | 4 | 940cf1e54d7c820e04946258a8b784f35c6a144c | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.24e-05 | 198 | 41 | 4 | 17dc055e2a289496d9c5cdbf3297bdf906dc6d22 | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-6_mon-Neuronal-Immature_CPNs|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 3.24e-05 | 198 | 41 | 4 | 4e598aab92141e7d32ec963291ddeed14a21beba | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Newborn-35|World / Primary Cells by Cluster | 3.24e-05 | 198 | 41 | 4 | de5214a85fe017eb23d4aa8af624464f062ec57e | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_|World / Primary Cells by Cluster | 3.31e-05 | 199 | 41 | 4 | 058373b4ac3cec2108cb24265628ff0a50646e33 | |
| ToppCell | Macroglial-Astrocytes-SLC14A1|Macroglial / cells hierarchy compared to all cells using T-Statistic | 3.37e-05 | 200 | 41 | 4 | 16f468217427921fa18c6d078ffa990eb019b257 | |
| ToppCell | Macroglial-Astrocytes|Macroglial / cells hierarchy compared to all cells using T-Statistic | 3.37e-05 | 200 | 41 | 4 | 941536b7c32f1e63c70535233b2ccce0cd7bf96e | |
| ToppCell | Macroglial-Astrocytes-SLC14A1---|Macroglial / cells hierarchy compared to all cells using T-Statistic | 3.37e-05 | 200 | 41 | 4 | d6fcbf4f4bc1b89a9929d7b114c6b907b6979900 | |
| ToppCell | Macroglial-Astrocytes-SLC14A1----L1-6|Macroglial / cells hierarchy compared to all cells using T-Statistic | 3.37e-05 | 200 | 41 | 4 | f861509b54185d89931db64da1b9d81986cc7938 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26-Neuronal|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 3.37e-05 | 200 | 41 | 4 | 306926cb7a847871641f02e03d52dc56fd55711c | |
| ToppCell | Macroglial-Astrocytes-SLC14A1--|Macroglial / cells hierarchy compared to all cells using T-Statistic | 3.37e-05 | 200 | 41 | 4 | 0442894c39eec69850c090957a5dc7bcecd21e04 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26-Neuronal-Cortical_neuron|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 3.37e-05 | 200 | 41 | 4 | 5b3df61ff421846ef4cabf1bd5355534c8b95509 | |
| ToppCell | Transverse-(7)_Mast_cell-(70)_Mast|Transverse / shred on region, Cell_type, and subtype | 3.37e-05 | 200 | 41 | 4 | aa17354c83b0967707d995e4b74e042ac211f814 | |
| ToppCell | Transverse-Mast_cell-Mast|Transverse / Region, Cell class and subclass | 3.37e-05 | 200 | 41 | 4 | 0af942a33cc50da65129204976e24203320e206d | |
| ToppCell | Macroglial-Astrocytes-SLC14A1-|Macroglial / cells hierarchy compared to all cells using T-Statistic | 3.37e-05 | 200 | 41 | 4 | 01819446deeab9054f5cfe889d53bb49d137dbc0 | |
| ToppCell | Transverse-Mast_cell|Transverse / Region, Cell class and subclass | 3.37e-05 | 200 | 41 | 4 | 5e3f5349ffbcabdca3d911fbc99a46aaa56c47c4 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Neuronal-Intermediate|5w / Sample Type, Dataset, Time_group, and Cell type. | 3.37e-05 | 200 | 41 | 4 | c92e4fc0442404481fcac623d691dae6215b852d | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW23-Neuronal-GABAergic_neurons|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 3.37e-05 | 200 | 41 | 4 | c6bbd33bca86ac7a76a7ba704b3e141237d04549 | |
| ToppCell | Transverse-(7)_Mast_cell|Transverse / shred on region, Cell_type, and subtype | 3.37e-05 | 200 | 41 | 4 | d90d1d3015a9258298bd6b4ba07971aa1af8b82b | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW23-Neuronal|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 9.46e-05 | 96 | 41 | 3 | 56e993d37b7958abe56682422536045550e29b41 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.42e-04 | 110 | 41 | 3 | bc1986e5a496a4d25da3445b6f252f81741619f4 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW23-Neuronal|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 1.49e-04 | 112 | 41 | 3 | 9c3fb470708e76a8f8a3cb9aa17ab130c60fee11 | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.12e-04 | 126 | 41 | 3 | 84dce108561d4b745d19250c2ac0667d9e4ea17d | |
| ToppCell | E16.5-samps-Mesenchymal-Myofibroblast-myofibroblast_-_immature|E16.5-samps / Age Group, Lineage, Cell class and subclass | 2.27e-04 | 129 | 41 | 3 | 5e4783cc63afdeaebdfaecb72f95f3efc8d3c4a3 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-OPC_related-Oligodendrocyte/OPC|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 3.01e-04 | 142 | 41 | 3 | 43e72e4b9ae33768672ef90c8bbfd2ca1818c746 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-OPC_related|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 3.01e-04 | 142 | 41 | 3 | d2d150e3019a5b7b143e50b1c1c2b6764abf36bf | |
| ToppCell | Control-NK|World / Disease group and Cell class | 3.07e-04 | 143 | 41 | 3 | fe08adc9472dfd4242497d6c614d0490713261da | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Myeloid-Dendritic-conventional_dendritic_cell|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.74e-04 | 153 | 41 | 3 | ee6f4770c6e35d59bdeec5b0ecb10119fa8c3ca5 | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-mo-Mac|Myeloid_cells / Location, Cell class and cell subclass | 3.74e-04 | 153 | 41 | 3 | 5424494ea1f09542799045a875cc3eac13de5079 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Myeloid-Dendritic-conventional_dendritic_cell-DC_c2-CD1C|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.74e-04 | 153 | 41 | 3 | 90cd6efda83c0b4b80eae2c90e7ff45dfd936dc2 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Myeloid-Dendritic|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.74e-04 | 153 | 41 | 3 | a35149a0c8b4ec9ad27cc4b3d34fba3b8714a6a2 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.18e-04 | 159 | 41 | 3 | 5ca96db4281abb5f646150ccf36adc66ab201c78 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Myeloid-Monocytic-Nonclassical_Monocyte|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.26e-04 | 160 | 41 | 3 | c9fe3438f747e2a98e3f27a56ba4c12a3789c2f2 | |
| ToppCell | lymphoid-T_cell-pro-T_cell|T_cell / Lineage, cell class and subclass | 4.26e-04 | 160 | 41 | 3 | 66fe86d2f37983761141e5bb3de127f0b4bb0951 | |
| ToppCell | Club_cells-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 4.34e-04 | 161 | 41 | 3 | 342f5c61d37df61b35c18f5d258043a8f5cef629 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.42e-04 | 162 | 41 | 3 | 5c9bc3c3857a99d8a3caf359a7eb279ce9cc1c81 | |
| ToppCell | Frontal_cortex|World / BrainAtlas - Mouse McCarroll V32 | 4.58e-04 | 164 | 41 | 3 | e09291711abf8680e78170328313719092b0142f | |
| ToppCell | moderate-Myeloid-Mast_cell|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.74e-04 | 166 | 41 | 3 | c3835b424c63bf11a4e2c47635dc3787fc4a637a | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Th|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 4.74e-04 | 166 | 41 | 3 | 6a6ed5c7a43fee9a8a9be42dfa99303815b8e8ef | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.83e-04 | 167 | 41 | 3 | b94e8ee8c3fcebedd8fcd719eadddc04c7513c50 | |
| ToppCell | Control-NK|Control / Disease group and Cell class | 4.91e-04 | 168 | 41 | 3 | 683d389c8a1e791bfc773e63148115a21a6566db | |
| ToppCell | droplet-Heart-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.00e-04 | 169 | 41 | 3 | 2e5bb6437bc9c614e337c5ffb6f6457cd9fc7f4c | |
| ToppCell | metastatic_Brain-B_lymphocytes-GrB-secreting_B_cells|metastatic_Brain / Location, Cell class and cell subclass | 5.00e-04 | 169 | 41 | 3 | 71f6761b9927f352e0ccc221ca373319915f4184 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-proliferative_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.00e-04 | 169 | 41 | 3 | a84490724a206c9bbb145f7ce08613f91d100ac4 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.08e-04 | 170 | 41 | 3 | fa753cc8fbd04e63c9a303da4dc17ee2ce907f92 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.08e-04 | 170 | 41 | 3 | 03044e1436443b28dd39d5ef4fdb25c18e3a7546 | |
| ToppCell | Control-Myeloid-Mast|Control / Disease state, Lineage and Cell class | 5.08e-04 | 170 | 41 | 3 | 9a14deb7f7cd4a49c217eba4023f7bf1dec6c902 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.08e-04 | 170 | 41 | 3 | a2c738e441ced90eeeb1fcc6ca3269b918aaa298 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.08e-04 | 170 | 41 | 3 | 876b84740e15399bfff2b9c7f0b80fd759bbdb3f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.08e-04 | 170 | 41 | 3 | 1f8738acf439d893880db7e1fdc9b3615ca00c39 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.08e-04 | 170 | 41 | 3 | 8ab67e2b6e30fdf9e9a2c02e31d4df34e751a3ed | |
| ToppCell | Control-Myeloid-Mast|World / Disease state, Lineage and Cell class | 5.17e-04 | 171 | 41 | 3 | ed8e61d524f4cddc6084b261175df54d2a64a60f | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.26e-04 | 172 | 41 | 3 | d354424c1f861b6607dfd63b9724f4c237b30275 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell_prolif|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.26e-04 | 172 | 41 | 3 | c056d44e2e130ceccadfcdceb192a7f095d779c8 | |
| ToppCell | 11.5-Distal-Mesenchymal-Mesenchyme_SERPINF1-high|Distal / Age, Tissue, Lineage and Cell class | 5.35e-04 | 173 | 41 | 3 | 6989c9cebcd81eccceac7e5a86152676ee959386 | |
| ToppCell | COVID-19-Myeloid-MoAM5,_CCL3L1|COVID-19 / Condition, Lineage and Cell class | 5.35e-04 | 173 | 41 | 3 | 502f888b7684ed39f5c577eedcacf673ae81d39e | |
| ToppCell | 15-Trachea-Mesenchymal-Mesenchyme_RSPO2+|Trachea / Age, Tissue, Lineage and Cell class | 5.44e-04 | 174 | 41 | 3 | fa0681e91724b9a51ee28b214ea5aa14e62ba1a3 | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.53e-04 | 175 | 41 | 3 | cf53a15bfb37b6019e7052ffdf594a9ac040900e | |
| ToppCell | Control-Myeloid-Mast|Myeloid / Disease state, Lineage and Cell class | 5.62e-04 | 176 | 41 | 3 | 0c5916d63e1ada09105e46d2429b75129b7329ec | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.62e-04 | 176 | 41 | 3 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.62e-04 | 176 | 41 | 3 | 64e426f5e84884ce2c29acf6f4b958962a63927f | |
| Drug | Perhexiline maleate [6724-53-4]; Up 200; 10.2uM; MCF7; HT_HG-U133A | 1.28e-05 | 169 | 41 | 5 | 7441_UP | |
| Drug | irinotecan HCl; Down 200; 100uM; PC3; HT_HG-U133A | 1.36e-05 | 171 | 41 | 5 | 7535_DN | |
| Drug | Prednisolone [50-24-8]; Up 200; 11uM; PC3; HT_HG-U133A | 2.37e-05 | 192 | 41 | 5 | 5101_UP | |
| Drug | Lynestrenol [52-76-6]; Up 200; 14uM; MCF7; HT_HG-U133A | 2.49e-05 | 194 | 41 | 5 | 5355_UP | |
| Drug | Suxibuzone [27470-51-5]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 2.62e-05 | 196 | 41 | 5 | 6065_DN | |
| Drug | Parbendazole [14255-87-9]; Down 200; 16.2uM; MCF7; HT_HG-U133A | 2.62e-05 | 196 | 41 | 5 | 3881_DN | |
| Disease | white matter microstructure measurement | 1.56e-05 | 390 | 41 | 6 | EFO_0005674 | |
| Disease | epilepsy | 2.56e-05 | 41 | 41 | 3 | EFO_0000474 | |
| Disease | Polyarthritis, Juvenile, Rheumatoid Factor Positive | 3.31e-05 | 131 | 41 | 4 | C4704862 | |
| Disease | Polyarthritis, Juvenile, Rheumatoid Factor Negative | 3.31e-05 | 131 | 41 | 4 | C4552091 | |
| Disease | Juvenile arthritis | 3.31e-05 | 131 | 41 | 4 | C3495559 | |
| Disease | Juvenile psoriatic arthritis | 3.31e-05 | 131 | 41 | 4 | C3714758 | |
| Disease | Juvenile-Onset Still Disease | 3.72e-05 | 135 | 41 | 4 | C0087031 | |
| Disease | alcohol consumption measurement | 4.17e-05 | 1242 | 41 | 9 | EFO_0007878 | |
| Disease | body weight | 4.70e-05 | 1261 | 41 | 9 | EFO_0004338 | |
| Disease | cognitive function measurement | 1.26e-04 | 1434 | 41 | 9 | EFO_0008354 | |
| Disease | myelodysplastic syndrome (implicated_via_orthology) | 1.96e-04 | 15 | 41 | 2 | DOID:0050908 (implicated_via_orthology) | |
| Disease | Antihistamine use measurement | 2.53e-04 | 17 | 41 | 2 | EFO_0009943 | |
| Disease | rhinitis | 2.53e-04 | 17 | 41 | 2 | EFO_0008521 | |
| Disease | Adenoid Cystic Carcinoma | 3.67e-04 | 100 | 41 | 3 | C0010606 | |
| Disease | pathological myopia | 4.98e-04 | 111 | 41 | 3 | EFO_0004207 | |
| Disease | age at first birth measurement | 6.25e-04 | 120 | 41 | 3 | EFO_0009101 | |
| Disease | systolic blood pressure, alcohol drinking | 7.53e-04 | 128 | 41 | 3 | EFO_0004329, EFO_0006335 | |
| Disease | very low density lipoprotein particle size measurement | 8.42e-04 | 133 | 41 | 3 | EFO_0008594 | |
| Disease | viral load | 8.98e-04 | 136 | 41 | 3 | EFO_0010125 | |
| Disease | seasonal allergic rhinitis | 9.10e-04 | 32 | 41 | 2 | EFO_0003956 | |
| Disease | triglyceride measurement, physical activity | 1.03e-03 | 34 | 41 | 2 | EFO_0003940, EFO_0004530 | |
| Disease | nasal disorder | 1.09e-03 | 35 | 41 | 2 | MONDO_0002436 | |
| Disease | bipolar disorder | 1.18e-03 | 577 | 41 | 5 | MONDO_0004985 | |
| Disease | Paroxysmal atrial fibrillation | 1.33e-03 | 156 | 41 | 3 | C0235480 | |
| Disease | familial atrial fibrillation | 1.33e-03 | 156 | 41 | 3 | C3468561 | |
| Disease | Persistent atrial fibrillation | 1.33e-03 | 156 | 41 | 3 | C2585653 | |
| Disease | Glucocorticoid use measurement | 1.35e-03 | 39 | 41 | 2 | EFO_0009942 | |
| Disease | dentate gyrus volume measurement | 1.35e-03 | 39 | 41 | 2 | EFO_0010083 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PSSASSSSSSSSSPF | 361 | P50548 | |
| SSSSSSSSGGPFQPA | 331 | P55198 | |
| SSSSSSSSSSASPFP | 386 | P54259 | |
| SSNGTASQSTSPSQP | 1066 | Q92793 | |
| SLSSSSSSGYSGQPN | 806 | O14529 | |
| QTGSPQNSNSSFSSS | 221 | Q76L83 | |
| PPSPSTTSSNNNSSS | 36 | P29558 | |
| APPSPSTNSSSNNSS | 36 | Q6XE24 | |
| SQANSPSTPNSAGSS | 321 | P40424 | |
| SSFPSSFPSSSSSSS | 46 | P43363 | |
| SSSSPSPSFQQQTSC | 1256 | Q8IWI9 | |
| SSYASNSSSPSRSPG | 431 | Q86X51 | |
| PQPSASSSSQFSTSG | 861 | O15054 | |
| GSNSSSSSSTFNPQA | 76 | P18146 | |
| SPSSGYSSQSNTPTA | 851 | Q5SYE7 | |
| GASSQSSSPASSTPN | 1151 | Q9Y2H9 | |
| SSSPASSTPNSPASS | 1156 | Q9Y2H9 | |
| SSSSSSSSFYNGSPP | 86 | P20393 | |
| PPASGASSNSSNATT | 341 | P43694 | |
| SNSSSSSGPNPSTSF | 321 | Q16254 | |
| SPSPSVSSATSQSSG | 1146 | Q96N67 | |
| STPDFPSGTNSSQSS | 1316 | O15021 | |
| PSGTNSSQSSSPSSS | 1321 | O15021 | |
| SSQSSSPSSSAPNSP | 1326 | O15021 | |
| VSNSSSGSSSSTPSP | 331 | Q7Z589 | |
| NSFQSSSSSVPSSPN | 31 | Q14995 | |
| SSSSVPSSPNSSNSD | 36 | Q14995 | |
| GPPSSSSSSSSSSSP | 46 | P78426 | |
| SYSSSNGGSTSSSPP | 586 | Q5U5Q3 | |
| AANSPFSSGSSVTSP | 1546 | Q8IVL1 | |
| LAPSFSSSSSSSSGP | 1456 | O43166 | |
| GSPPASSTSSSSLTN | 876 | Q8N122 | |
| SSPSSSSAASSSSPG | 106 | Q9Y4X0 | |
| SGSSPSSSSAPLASF | 2291 | Q8IWZ3 | |
| GTSSSSTPSTAQSPA | 921 | Q2KHT3 | |
| SSGSSSSSSTPSSQP | 726 | Q9UKE5 | |
| SSSSTPSSQPSSQGG | 731 | Q9UKE5 | |
| AGSGSNNSPSSSSSP | 121 | O95271 | |
| NNSPSSSSSPTSSSS | 126 | O95271 | |
| NTSDSGNSFTTSSPQ | 326 | A7MD48 | |
| SSPSSSSPSSSGSSP | 166 | Q17RH7 | |
| SSPSSSGSSPSSSNS | 171 | Q17RH7 | |
| SGSSPSSSNSSPSSS | 176 | Q17RH7 | |
| QSSASSSSSSSFPSP | 236 | Q9UGU0 | |
| GSGNPNSNSTSTSTS | 161 | Q9ULD9 | |
| GSSPNSVSSSPTNSA | 351 | O60315 | |
| PASSNSSGSLSPSSS | 731 | Q59H18 | |
| SGTSCPSSKNSSPNS | 1181 | P35125 | |
| SPSSSSSSFNPLNGT | 81 | Q9NR64 |